Drug-safety indicators are the first fruits of a collaboration between academia, industry and regulators.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Dieterle, F. et al. Nature Biotechnol. 28, 463-469 (2010).
Vaidya, V. S. et al. Nature Biotechnol. 28, 478-485 (2010).
Yu, Y. et al. Nature Biotechnol. 28, 470-477 (2010).
Ozer, J. S. et al. Nature Biotechnol. 28, 486-494 (2010).
Related links
Rights and permissions
About this article
Cite this article
Borrell, B. Biomarkers for kidney damage should speed drug development. Nature (2010). https://doi.org/10.1038/news.2010.232
Published:
DOI: https://doi.org/10.1038/news.2010.232